drugset / Trial / NCT05724550
Diaphragm Function After Reversal of Rocuronium-induced Neuromuscular Blockade With Sugammadex or Neostigmine in Children
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study is to evaluate the recovery of diaphragm function and atelectasis after reversal of neuromuscular blockade with Neostigmine and Sugammadex using lung ultrasound and diaphragm ultrasound for children aged 2 to 7 who are scheduled for the surgical procedure under general anesthesia.
Timeline
- Start
- 2023-02-22
- Primary completion
- 2024-06-07
- Completion
- 2024-06-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 0.02 mg/kg | — |
| Subject | Sugammadex | Other / unclassified | 2 mg/kg | — |